SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Takuro Kuriyama, Noriaki Kawano, Kiyoshi Yamashita, Akira Ueda, Successful Treatment of Rituximab-Resistant Epstein-Barr Virus-Associated Post-transplant Lymphoproliferative Disorder Using R-CHOP, Journal of Clinical and Experimental Hematopathology, 2014, 54, 2, 149

    CrossRef

  2. 2
    Damian L. Turner, Claire L. Gordon, Donna L. Farber, Tissue-resident T cells, in situ immunity and transplantation, Immunological Reviews, 2014, 258, 1
  3. 3
    Peter Jaksch, Dominik Wiedemann, Alfred Kocher, Gabriella Muraközy, Victoria Augustin, Walter Klepetko, Effect of Cytomegalovirus Immunoglobulin on the Incidence of Lymphoproliferative Disease After Lung Transplantation, Transplantation Journal, 2013, 95, 5, 766

    CrossRef

  4. 4
    Ricardo M. La Hoz, John W. Baddley, Infectious Complications of Immune Modulatory Agents, Current Infectious Disease Reports, 2013, 15, 6, 465

    CrossRef

  5. 5
    D. Michonneau, F. Suarez, J. Lambert, J. Adam, N. Brousse, D. Canioni, D. Anglicheau, F. Martinez, R. Snanoudj, C. Legendre, O. Hermine, M.-F. Mamzer-Bruneel, Late-onset post-transplantation lymphoproliferative disorders after kidney transplantation: a monocentric study over three decades, Nephrology Dialysis Transplantation, 2013, 28, 2, 471

    CrossRef

  6. 6
    Esther Ramos, Francisco Hernández, Ane Andres, Eva Martínez-Ojinaga, Manuel Molina, Jesús Sarría, Manuel Lopez-Santamaria, Gerardo Prieto, Post-transplant lymphoproliferative disorders and other malignancies after pediatric intestinal transplantation: Incidence, clinical features and outcome, Pediatric Transplantation, 2013, 17, 5
  7. 7
    Isabel P. Neuringer, Posttransplant Lymphoproliferative Disease after Lung Transplantation, Clinical and Developmental Immunology, 2013, 2013, 1

    CrossRef

  8. 8
    Norihide Fukushima, Posttransplant Lymphoproliferative Disorder after Cardiac Transplantation in Children: Life Threatening Complications Associated with Chemotherapy Combined with Rituximab, ISRN Transplantation, 2013, 2013, 1

    CrossRef

  9. 9
    Daan Dierickx, Thomas Tousseyn, Xavier Sagaert, Steffen Fieuws, Iwona Wlodarska, Julie Morscio, Lieselot Brepoels, Dirk Kuypers, Johan Vanhaecke, Frederik Nevens, Geert Verleden, Rita Van Damme-Lombaerts, Marleen Renard, Jacques Pirenne, Christiane De Wolf-Peeters, Gregor Verhoef, Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors, Leukemia & Lymphoma, 2013, 54, 11, 2433

    CrossRef

  10. 10
    Michael A. Linden, Veronika Bachanova, Zohar Sachs, Jo-Anne H. Young, Timothy P. Singleton, Celalettin Ustun, Transformed large B-cell lymphoma in rituximab-allergic patient with chronic lymphocytic leukemia after allogeneic stem cell transplant: successful treatment with ofatumumab, Leukemia & Lymphoma, 2013, 54, 1, 174

    CrossRef

  11. 11
    Natasha Chandok, Kymberly D. Watt, Burden of de novo malignancy in the liver transplant recipient, Liver Transplantation, 2012, 18, 11
  12. 12
    M. Green, M. G. Michaels, Infections in Pediatric Solid Organ Transplant Recipients, Journal of the Pediatric Infectious Diseases Society, 2012, 1, 2, 144

    CrossRef

  13. 13
    Brandon E. Kremer, Ran Reshef, Jamal G. Misleh, Jason D. Christie, Vivek N. Ahya, Nancy P. Blumenthal, Robert M. Kotloff, Denis Hadjiliadis, Edward A. Stadtmauer, Stephen J. Schuster, Donald E. Tsai, Post-transplant lymphoproliferative disorder after lung transplantation: A review of 35 cases, The Journal of Heart and Lung Transplantation, 2012, 31, 3, 296

    CrossRef

  14. 14
    Emina Emilia Torlakovic, Denis Bailey, Post-transplant lymphoproliferative disorders, Diagnostic Histopathology, 2012, 18, 7, 281

    CrossRef

  15. 15
    Chikashi Nakanishi, Naoki Kawagishi, Satoshi Sekiguchi, Yorihiro Akamatsu, Kazushige Sato, Shigehito Miyagi, Ikuo Takeda, Daizo Fukushima, Yoshinobu Kobayashi, Kazuyuki Ishida, Hidetaka Niizuma, Shigeru Tsuchiya, Motoshi Wada, Masaki Nio, Susumu Satomi, Post-transplantation lymphoproliferative disorder in living-donor liver transplantation: a single-center experience, Surgery Today, 2012, 42, 8, 741

    CrossRef

  16. 16
    Ralf Trappe, Stephan Oertel, Veronique Leblond, Peter Mollee, Monica Sender, Petra Reinke, Ruth Neuhaus, Hans Lehmkuhl, Heinz August Horst, Gilles Salles, Franck Morschhauser, Arnaud Jaccard, Thierry Lamy, Malte Leithäuser, Heiner Zimmermann, Ioannis Anagnostopoulos, Martine Raphael, Hanno Riess, Sylvain Choquet, Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial, The Lancet Oncology, 2012, 13, 2, 196

    CrossRef

  17. 17
    Denis Glotz, Jeremy R. Chapman, Vikas R. Dharnidharka, Douglas W. Hanto, Maria C.R. Castro, Hans H. Hirsch, Véronique Leblond, Aneesh K. Mehta, Bruno Moulin, Antonio Pagliuca, Julio Pascual, Alan B. Rickinson, Francesco P. Russo, Ralf U. Trappe, Angela C. Webster, Andreas O. Zuckermann, Thomas G. Gross, The Seville Expert Workshop for Progress in Posttransplant Lymphoproliferative Disorders, Transplantation Journal, 2012, 94, 8, 784

    CrossRef

  18. 18
    Mario Senechal, Sabrina Demers, Bernard Cantin, Christine Bourgault, Marie-Helene Leblanc, Joëlle Morin, Christian Couture, Usefulness and Limitations of Rituximab in Managing Patients With Lymphoproliferative Disorder After Heart Transplantation, Experimental and Clinical Transplantation, 2012, 10, 5, 513

    CrossRef

  19. 19
    A. Patrick, A. Wee, A. Hedderman, D. Wilson, J. Weiss, M. Govani, High-dose intravenous rituximab for multifocal, monomorphic primary central nervous system posttransplant lymphoproliferative disorder, Journal of Neuro-Oncology, 2011, 103, 3, 739

    CrossRef

  20. 20
    Daan Dierickx, Thomas Tousseyn, Christiane De Wolf-Peeters, Jacques Pirenne, Gregor Verhoef, Management of posttransplant lymphoproliferative disorders following solid organ transplant: an update, Leukemia & Lymphoma, 2011, 52, 6, 950

    CrossRef

  21. 21
    Kitsada Wudhikarn, C.J. Holman, M. Linan, A.H. Blaes, J.M. Dunitz, M.E. Hertz, B.A. Peterson, Post-transplant lymphoproliferative disorders in lung transplant recipients: 20-yr experience at the University of Minnesota, Clinical Transplantation, 2011, 25, 5
  22. 22
    Kala Y Kamdar, Cliona M Rooney, Helen E Heslop, Posttransplant lymphoproliferative disease following liver transplantation, Current Opinion in Organ Transplantation, 2011, 16, 3, 274

    CrossRef

  23. 23
    Arun Swaminath, Cynthia M. Magro, Edward Dwyer, Refractory Urticarial Vasculitis as a Complication of Ulcerative Colitis Successfully Treated With Rituximab, Journal of Clinical Rheumatology, 2011, 17, 5, 281

    CrossRef

  24. 24
    S. Miyagi, S. Sekiguchi, N. Kawagishi, Y. Akamatsu, K. Satoh, I. Takeda, D. Fukushima, Y. Kobayashi, K. Tokodai, K. Fujimori, S. Satomi, Rituximab Therapy and Reduction of Immunosuppression to Rescue Graft Function After Renal Posttransplantation Lymphoproliferative Disorder Found by Macrohematuria in a Pancreas and Kidney Transplant Recipient: A Case Report, Transplantation Proceedings, 2011, 43, 9, 3299

    CrossRef

  25. 25
    Stefania Coppoletta, Elisabetta Tedone, Barbara Galano, Monica Soracco, Anna Maria Raiola, Teresa Lamparelli, Francesca Gualandi, Stefania Bregante, Adalberto Ibatici, Carmen di Grazia, Alida Dominietto, Riccardo Varaldo, Barbara Bruno, Francesco Frassoni, MariaTeresa Van Lint, Andrea Bacigalupo, Rituximab Treatment for Epstein-Barr Virus DNAemia after Alternative-Donor Hematopoietic Stem Cell Transplantation, Biology of Blood and Marrow Transplantation, 2011, 17, 6, 901

    CrossRef

  26. 26
    Ji-Min Jeon, Joon-Suk Oh, Sung-Min Kim, Yoong-Gi Son, Yong-Ki Park, Yong-Hun Sin, Joong-Kyung Kim, Yong-Jin Kim, Combination Treatment of Rituximab and Plasmapheresis in Acute Cellular Rejection with Focal Segmental Glomerular Sclerosis after Renal Transplantation, The Journal of the Korean Society for Transplantation, 2010, 24, 1, 30

    CrossRef

  27. 27
    Mark A. Marinella, Hematologic abnormalities following renal transplantation, International Urology and Nephrology, 2010, 42, 1, 151

    CrossRef

  28. 28
    Donald R Shaffer, Cliona M Rooney, Stephen Gottschalk, Immunotherapeutic options for Epstein–Barr virus-associated lymphoproliferative disease following transplantation, Immunotherapy, 2010, 2, 5, 663

    CrossRef

  29. 29
    Inés Rama, Josep M. Grinyó, Malignancy after renal transplantation: the role of immunosuppression, Nature Reviews Nephrology, 2010, 6, 9, 511

    CrossRef

  30. You have free access to this content30
    Anne Parker, Kristin Bowles, J. Andrew Bradley, Vincent Emery, Carrie Featherstone, Girish Gupte, Robert Marcus, Jayan Parameshwar, Alan Ramsay, Charles Newstead, Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients – BCSH and BTS Guidelines, British Journal of Haematology, 2010, 149, 5
  31. 31
    K. Mucha, B. Foroncewicz, B. Ziarkiewicz-Wroblewska, M. Krawczyk, J. Lerut, L. Paczek, Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease?, Nephrology Dialysis Transplantation, 2010, 25, 7, 2089

    CrossRef

  32. 32
    Anne H Blaes, Vicki A Morrison, Post-transplant lymphoproliferative disorders following solid-organ transplantation, Expert Review of Hematology, 2010, 3, 1, 35

    CrossRef

  33. 33
    Jeremy A. Falk, Scott Oh, C. Joyce Lee, Hari Reddy, George E. Chaux, Michael I. Lewis, Medical Management of the Thoracic Surgery Patient, 2010,

    CrossRef

  34. 34
    U. Allen, J. Preiksaitis, Epstein-Barr Virus and Posttransplant Lymphoproliferative Disorder in Solid Organ Transplant Recipients, American Journal of Transplantation, 2009, 9,
  35. 35
    H. E. Heslop, How I treat EBV lymphoproliferation, Blood, 2009, 114, 19, 4002

    CrossRef

  36. 36
    Hideaki Ohta, Norihide Fukushima, Keiichi Ozono, Pediatric post-transplant lymphoproliferative disorder after cardiac transplantation, International Journal of Hematology, 2009, 90, 2, 127

    CrossRef

  37. 37
    Anne H. Blaes, Adina M. Cioc, Jerry W. Froelich, Bruce A. Peterson, Jordan M. Dunitz, Positron emission tomography scanning in the setting of post-transplant lymphoproliferative disorders, Clinical Transplantation, 2009, 23, 6
  38. 38
    Imran Ahmad, Nguyen V. Cau, John Kwan, Younes Maaroufi, Nathalie Meuleman, Mickael Aoun, Philippe Lewalle, Philippe Martiat, Françoise Crokaert, Dominique Bron, Preemptive Management of Epstein-Barr Virus Reactivation After Hematopoietic Stem-Cell Transplantation, Transplantation, 2009, 87, 8, 1240

    CrossRef

  39. 39
    Luca Dello Strologo, Isabella Guzzo, Chiara Laurenzi, Marina Vivarelli, Angelica Parodi, Giancarlo Barbano, Roberta Camilla, Floriana Scozzola, Alessandro Amore, Fabrizio Ginevri, Luisa Murer, Use of Rituximab in Focal Glomerulosclerosis Relapses After Renal Transplantation, Transplantation, 2009, 88, 3, 417

    CrossRef

  40. 40
    Mark Chaballa, Joanne Filicko-O'Hara, Dorothy Holt, Adam M. Frank, John L. Wagner, Dolores Grosso, Neal Flomenberg, Pharmacology and Therapeutics, 2009,

    CrossRef

  41. 41
    Patrick Garceau, Christian Couture, Bernard Cantin, Vincent Bernier, Mario Sénéchal, Epstein–Barr Virus Polymerase Chain Reaction–negative Stage IV Post-transplant Lymphoproliferative Disorder in a Heart Transplant Patient Treated With Rituximab, The Journal of Heart and Lung Transplantation, 2008, 27, 8, 928

    CrossRef

  42. 42
    Stephan A. Grupp, Michael Verneris, Paul M. Sondel, Laurence J.N. Cooper, Immunotherapy for Pediatric Cancer, Biology of Blood and Marrow Transplantation, 2008, 14, 1, 33

    CrossRef

  43. 43
    Hsin-Yun Sun, Nina Singh, Pharmacotherapy of post-transplant viral infections, Expert Opinion on Pharmacotherapy, 2008, 9, 14, 2409

    CrossRef

  44. 44
    B. Sprangers, S. Smets, X. Sagaert, A. Wozniak, E. Wollants, M. Van Ranst, M. Debiec-Rychter, R. Sciot, Y. Vanrenterghem, D. R. Kuypers, Posttransplant Epstein-Barr Virus-Associated Myogenic Tumors: Case Report and Review of the Literature, American Journal of Transplantation, 2008, 8, 1
  45. 45
    Megan L. Troxell, Jennifer B. Dunlap, Anuja Mittalhenkle, Mona Ishag, Guang Fan, James Z. Huang, Ken Gatter, Dan M. Byrd, Devon Webster, Donald C. Houghton, Rejection Versus Posttransplantation Lymphoproliferative Disorder in a Renal Transplant Recipient, American Journal of Kidney Diseases, 2008, 52, 6, 1174

    CrossRef

  46. 46
    Jürgen Rademaker, Hodgkin's and Non-Hodgkin's Lymphomas, Radiologic Clinics of North America, 2007, 45, 1, 69

    CrossRef

  47. 47
    B Coiffier, Rituximab therapy in malignant lymphoma, Oncogene, 2007, 26, 25, 3603

    CrossRef

  48. 48
    Thomas Lowe, Smita Bhatia, George Somlo, Second Malignancies after Allogeneic Hematopoietic Cell Transplantation, Biology of Blood and Marrow Transplantation, 2007, 13, 10, 1121

    CrossRef

  49. 49
    Georg Schlieper, Christine Kurschat, Andreas Donner, Wolfgang Huckenbeck, Thomas Rüdiger, Wilhelm Sandmann, Bernd Grabensee, Katrin Ivens, Peter Heering, Hodgkin Disease–Like Posttransplantation Lymphoproliferative Disorder of Donor Origin in a Renal Allograft Recipient, American Journal of Kidney Diseases, 2006, 47, 3, e37

    CrossRef

  50. 50
    Eun Ji Kwon, Kenneth A. Katz, Karla S. Draft, John T. Seykora, Alain H. Rook, Mariusz A. Wasik, Jacqueline M. Junkins-Hopkins, Posttransplantation lymphoproliferative disease with features of lymphomatoid granulomatosis in a lung transplant patient, Journal of the American Academy of Dermatology, 2006, 54, 4, 657

    CrossRef

  51. 51
    WAI H LIM, GRAEME R RUSS, PATRICK TH COATES, Review of Epstein–Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation (Review Article), Nephrology, 2006, 11, 4
  52. 52
    Susan G Fisher, Richard I Fisher, The emerging concept of antigen-driven lymphomas: epidemiology and treatment implications, Current Opinion in Oncology, 2006, 18, 5, 417

    CrossRef

  53. 53
    Yolanda T. Becker, Milagros Samaniego-Picota, Hans W. Sollinger, The emerging role of rituximab in organ transplantation, Transplant International, 2006, 19, 8
  54. 54
    Michael Green, Steven A. Webber, Post-Transplant Lymphoproliferative Disorders,
  55. 55
    Axel Böhnke, Michael Wenger, Rituximab (Rituxan®),
  56. 56
    Mark D. Pescovitz, Rituximab, an Anti-CD20 Monoclonal Antibody,
  57. 57
    Experimental and Clinical Transplantation,

    CrossRef